FENTORA® (fentanyl buccal tablet)[C-II]
Download prescribing information |
| Breakthrough pain associated with specific chronic pain conditions in opioid tolerant patients |
sNDA Filed |
|
NUVIGIL™ (armodafinil) [C-IV] Tablets
Download prescribing information |
| Bipolar depression |
Phase 2 |
Excessive sleepiness in traumatic brain injury
and other medical conditions |
Phase 2 |
| Cancer related fatigue |
Phase 2 |
| Negative symptoms in schizophrenia |
Phase 3 |
|
TRISENOX® (arsenic trioxide) for Injection
Download prescribing information |
|
Acute Myeloid Leukemia
|
Phase 3
|
|
TREANDA®
(bendamustine hydrochloride) for Injection
Download prescribing information |
| Indolent Non-Hodgkin's Lymphoma |
NDA Filed |
|
| CEP-701 (lestaurtinib) |
|
Acute myelogenous leukemia (FLT3)
|
Phase 3
|
|
Myeloproliferative disorders (JAK2)
|
Phase 2
|
|
CEP-11981
(VEGF-R/TIE2 Kinase inhibitor) |
|
CEP-18770
(proteasome inhibitor) |
|
| CEP-28190 |
| Tamper-resistant opioid |
Phase 1 |
|